SCHEMBL4607883

SCHEMBL4607883

CSc1nsc(-c2cccc(F)c2F)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
TSHR P16473 3/20 0.36
GRK6 P43250 1/20 0.35
KMT2A Q03164 6/20 0.33
MEN1 O00255 4/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
CASP3 P42574 1/20 0.32
SENP8 Q96LD8 1/20 0.32
SENP7 Q9BQF6 1/20 0.32
HSD11B1 P28845 1/20 0.32
JAK2 O60674 1/20 0.32
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4603390 0.89 TSHR (0.42) MAPK1TDP1TSHRKMT2AMEN1
SCHEMBL4605715 0.74 HSP90AA1 (0.49) MAPK1TDP1TSHRKMT2AMEN1
SCHEMBL4607588 0.72 KDM4E (0.43) MAPK1TDP1KMT2AMEN1MAPT
SCHEMBL4605489 0.69 ADORA3 (0.53) MAPK1TDP1TSHRKMT2AMEN1
SCHEMBL10550071 0.69 GAA (0.47) TDP1TSHRKMT2AMEN1ALDH1A1
SCHEMBL3038641 0.69 CES2 (0.46) GRK6NPC1HSD11B1BCAT1DCUN1D1
SCHEMBL4606464 0.67 GRK6 (0.30) GRK6
SCHEMBL2091889 0.67 PDE10A (0.45) MAPK1TDP1KMT2AMEN1ALDH1A1
SCHEMBL5378284 0.66 TDP1 (0.39) MAPK1TDP1TSHRKMT2AMEN1
SCHEMBL4606116 0.66 KMT2A (0.43) KMT2ALMNACYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1574505-B1 1,2,4-THIADIAZOLE COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL CO (JP) 2008-07-16 EP disclosed
US-7361675-B2 1,2,4-thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2008-04-22 US disclosed
US-20060167266-A1 1,2,4- thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-07-27 US disclosed
EP-1574505-A1 1,2,4-THIADIAZOLE COMPOUNDS AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2005-09-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060167266-A1 1,2,4- thiadiazole compounds and use thereof CBR3, CBR1, NOX3 MAPK1 1437/4885TDP1 2099/4885TSHR 95/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.